Khalifa Medical City plans to introduce genetic testing for tumors



[ad_1]

Abu Dhabi: Rania Al-Ghazzawi

The Medical City of Sheikh Khalifa (SKMC), one of the facilities of the Abu Dhabi Health Services Company (SEHA), plans to perform genetic testing for tumors as part of the advanced diagnostic tests available in his laboratories. It also helps in identifying the appropriate treatment plan, based on the genetic mutation of the tumor, where the biopsy is taken from the tumor and examining the cells accurately, thus providing the accuracy of the treatment.
Dr. Rawia Mubarak Hamad, a pathologist who specializes in the diagnosis of brain and neurological tumors, said the city was providing the latest pigments used by Amonhohisto Chemistry, a sophisticated cancer cell microscopy device, that determines the type of cells that can be used to determine cancer. type of tumor. The tumor, at any stage, helps the pigments used to access an accurate diagnosis, and rare cases are diagnosed, tumors of the brain area, pituitary glands located beneath the brain and glands located in the brain cavity, pointing out that some of these cases have been diagnosed. In comparison with the results of the diagnosis in the largest international laboratories in America, the diagnosis corresponds to the scientific development and research carried out by the health sector in the country.
She mentioned some cases diagnosed and participated in her presentation at the International Conference of the Academy of Pathology, which was held for the first time in the Middle East in Jordan, especially in a child with diabetes. 39, a tumor in the middle of the brain and rare because of a rare genetic mutation. A rare tumor is usually diagnosed in the cartilage or bones, but its rarity is that it is a person in the brain and its incidence is less than 1%, thanks to the expertise of the neurosurgery of the city. .
Every year, more than 70 cases are diagnosed in adults and children with brain tumors. Meningoma is one of the most commonly diagnosed tumors in the city's pathology laboratories, most of which are benign tumors. Oncology is estimated at 35%; it is difficult to diagnose the meningeal tumor that affects the membranes surrounding the central nervous system. It develops slowly. Some of these rare forms appear under the microscope. A doctor, if he does not have experience, may not diagnose them properly.
She explained that the medicine of pathology and analysis of tissues and cells, is one of the disciplines of exact and rare globally and necessary, while the task of a Pathology specialist in the past was limited to the diagnosis of the tumor.

[ad_2]
Source link